You are here: Industry Insights > COVID-19 vaccine

News List

Risk for Myocarditis in Young Who Get Moderna Shots May Be Greater Than Thought drugs
August 23, 2021
The Moderna COVID-19 vaccine may be linked to a higher risk for myocarditis in younger adults than believed, emerging reports show.
Pfizer, BioNTech's COVID-19 vaccine on brink of full FDA approval firstwordpharma
August 23, 2021
According to people familiar with the matter, the FDA is expected to grant full approval to Pfizer and BioNTech's COVID-19 vaccine BNT162b2 as soon as Monday, The New York Times reported.
GeoVax Labs Shares Jump After Presenting Early COVID-19 Vaccine Data at European Meeting firstwordpharma
August 23, 2021
Shares in GeoVax Labs were up as much as 36% Friday after the company presented data from ongoing studies of its preventive vaccine against COVID-19 at the European Society of Medicine (ESMED) general assembly, as reported in Fidelity.
Statement on Boosting with the Johnson & Johnson COVID-19 Vaccine drugs
August 20, 2021
We are engaging with the U.S. FDA, CDC and other health authorities and will share new data shortly regarding boosting with the Johnson & Johnson COVID-19 vaccine.
Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response and Protection in Preclinical Study drugs
August 20, 2021
CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), and GSK today announced the publication of preclinical data investigating immune responses.
Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine drugs
August 20, 2021
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that they have submitted Phase 1 data to the U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the companies’ COVID-19 vaccine.
Sorrento Announces Its Lead Protein-Based COVID-19 Vaccine Candidate – DYAI-100 – Elicits Strong Neutralizing Immune Responses in Vaccinated Animals Against SARS-CoV-2 and Multiple Major Variants of C firstwordpharma
August 20, 2021
Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain .
GeoVax Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly firstwordpharma
August 20, 2021
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today presented data from ongoing studies of its preventive vaccine against COVID-19.
Changing of the guard at J&J as Joaquin Duato named to top job starting January firstwordpharma
August 20, 2021
Johnson & Johnson said Thursday that long-time CEO and chairman Alex Gorsky will be stepping down from his role and handing over the reins to his deputy, executive committee vice-chairman Joaquin Duato, effective January 3. At that point.
UK authorises Moderna's COVID-19 vaccine Spikevax for adolescents firstwordpharma
August 18, 2021
The Medicines and Healthcare products Regulatory Agency (MHRA) on Tuesday extended the conditional authorisation for Moderna's mRNA COVID-19 vaccine Spikevax, allowing it to be given to 12- to 17-year-olds in Great Britain.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page